Insulin resistance is strongly associated with type II diabetes. "Diabetogenic" factors including FFA, TNFalpha and cellular stress induce insulin resistance through inhibition of IRS1 functions. Serine/threonine phosphorylation, interaction with SOCS, regulation of the expression, modification of the cellular localization, and degradation represent the molecular mechanisms stimulated by them. Various kinases (ERK, JNK, IKKbeta, PKCzeta, PKCtheta and mTOR) are involved in this process.
The development of type II diabetes requires impaired beta-cell function. Chronic hyperglycemia has been shown to induce multiple defects in beta-cells. Hyperglycemia has been proposed to lead to large amounts of reactive oxygen species (ROS) in beta-cells, with subsequent damage to cellular components including PDX-1. Loss of PDX-1, a critical regulator of insulin promoter activity, has also been proposed as an important mechanism leading to beta-cell dysfunction.
Although there is little doubt as to the importance of genetic factors in type II diabetes, genetic analysis is difficult due to complex interaction among multiple susceptibility genes and between genetic and environmental factors. Genetic studies have therefore given very diverse results. Kir6.2 and IRS are two of the candidate genes. It is known that Kir6.2 and IRS play central roles in insulin secretion and insulin signal transmission, respectively.

Human Diseases; Endocrine and metabolic diseases

Homo sapiens (human) [GN:hsa]

PMID:15823385

Stumvoll M, Goldstein BJ, van Haeften TW.

Type 2 diabetes: principles of pathogenesis and therapy.

Lancet 365:1333-46 (2005)
DOI:10.1016/S0140-6736(05)61032-X

PMID:15733744

Gual P, Le Marchand-Brustel Y, Tanti JF.

Positive and negative regulation of insulin signaling through IRS-1 phosphorylation.

Biochimie 87:99-109 (2005)
DOI:10.1016/j.biochi.2004.10.019

PMID:11078440

Henquin JC.

Triggering and amplifying pathways of regulation of insulin secretion by glucose.

Diabetes 49:1751-60 (2000)
DOI:10.2337/diabetes.49.11.1751

PMID:11272200

Chandra J, Zhivotovsky B, Zaitsev S, Juntti-Berggren L, Berggren PO, Orrenius S.

Role of apoptosis in pancreatic beta-cell death in diabetes.

Diabetes 50 Suppl 1:S44-7 (2001)
DOI:10.2337/diabetes.50.2007.S44

PMID:15759102

Kaneto H, Matsuoka TA, Nakatani Y, Kawamori D, Miyatsuka T, Matsuhisa M, Yamasaki Y.

Oxidative stress, ER stress, and the JNK pathway in type 2 diabetes.

J Mol Med 83:429-39 (2005)
DOI:10.1007/s00109-005-0640-x

PMID:12480546

Sakai K, Matsumoto K, Nishikawa T, Suefuji M, Nakamaru K, Hirashima Y, Kawashima J, Shirotani T, Ichinose K, Brownlee M, Araki E.

Mitochondrial reactive oxygen species reduce insulin secretion by pancreatic beta-cells.

Biochem Biophys Res Commun 300:216-22 (2003)
DOI:10.1016/S0006-291X(02)02832-2

PMID:11390407

Kaneto H, Xu G, Song KH, Suzuma K, Bonner-Weir S, Sharma A, Weir GC.

Activation of the hexosamine pathway leads to deterioration of pancreatic beta-cell function through the induction of oxidative stress.

J Biol Chem 276:31099-104 (2001)
DOI:10.1074/jbc.M104115200

PMID:9011569

Matsuoka T, Kajimoto Y, Watada H, Kaneto H, Kishimoto M, Umayahara Y, Fujitani Y, Kamada T, Kawamori R, Yamasaki Y.

Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells.

J Clin Invest 99:144-50 (1997)
DOI:10.1172/JCI119126

PMID:7491105

Sharma A, Olson LK, Robertson RP, Stein R.

The reduction of insulin gene transcription in HIT-T15 beta cells chronically exposed to high glucose concentration is associated with the loss of RIPE3b1 and STF-1 transcription factor expression.

Mol Endocrinol 9:1127-34 (1995)
DOI:10.1210/mend.9.9.7491105

PMID:15258147

Robertson RP.

Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes.

J Biol Chem 279:42351-4 (2004)
DOI:10.1074/jbc.R400019200

PMID:9974390

Eto K, Tsubamoto Y, Terauchi Y, Sugiyama T, Kishimoto T, Takahashi N, Yamauchi N, Kubota N, Murayama S, Aizawa T, Akanuma Y, Aizawa S, Kasai H, Yazaki Y, Kadowaki T.

Role of NADH shuttle system in glucose-induced activation of mitochondrial metabolism and insulin secretion.

Science 283:981-5 (1999)
DOI:10.1126/science.283.5404.981

PMID:11325516

Novelli M, Fabregat ME, Fernandez-Alvarez J, Gomis R, Masiello P.

Metabolic and functional studies on isolated islets in a new rat model of type 2 diabetes.

Mol Cell Endocrinol 175:57-66 (2001)
DOI:10.1016/S0303-7207(01)00400-2

PMID:15585596

Yang SN, Berggren PO.

Beta-cell CaV channel regulation in physiology and pathophysiology.

Am J Physiol Endocrinol Metab 288:E16-28 (2005)
DOI:10.1152/ajpendo.00042.2004